Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
39.49
+2.50 (6.76%)
At close: Apr 2, 2026, 4:00 PM EDT
39.60
+0.11 (0.28%)
After-hours: Apr 2, 2026, 7:59 PM EDT

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0392,4212,0541,27581164
Market Cap Growth
-8.86%17.84%61.12%1478.46%-50.66%-78.69%
Enterprise Value
1,5852,1671,8151,10566.18142.59
Last Close Price
39.4946.3044.9540.259.9030.75
PE Ratio
101.26118.72-10.26-17.06-3.45-5.29
Forward PE
10.1513.68----
PS Ratio
10.7112.71----
PB Ratio
4.595.388.388.107.819.20
P/TBV Ratio
4.525.397.374.218.039.19
P/FCF Ratio
43.6351.81-29.64-51.12-3.88-5.89
P/OCF Ratio
43.5651.73-29.73-51.12-3.89-5.90
EV/Sales Ratio
8.3211.38----
EV/EBITDA Ratio
93.42189.59-9.78-28.04-2.95-4.82
EV/EBIT Ratio
106.03230.21-9.67-26.71-2.71-4.52
EV/FCF Ratio
33.9246.38-26.19-44.33-3.18-5.13
Debt / Equity Ratio
0.120.120.210.0000.01
Debt / EBITDA Ratio
4.604.60-0.28-0.01-0.01-0.01
Debt / FCF Ratio
1.131.13-0.76-0.02-0.01-0.02
Net Debt / Equity Ratio
-0.56-0.56-0.97-1.07-1.40-1.17
Net Debt / EBITDA Ratio
-22.13-22.131.294.290.640.71
Net Debt / FCF Ratio
-5.41-5.413.446.790.700.75
Asset Turnover
0.070.430000
Inventory Turnover
0.360.36----
Quick Ratio
5.445.4415.5514.752.002.66
Current Ratio
5.805.8015.6814.892.142.80
Return on Equity (ROE)
6.01%6.01%-87.35%-46.45%-171.05%-97.60%
Return on Assets (ROA)
2.10%2.10%-73.36%-39.95%-78.64%-62.72%
Return on Invested Capital (ROIC)
7.18%7.18%-1379.43%-1262.86%-404.33%-440.27%
Return on Capital Employed (ROCE)
2.31%2.31%-77.97%-43.94%-104.42%-75.15%
Earnings Yield
1.00%0.84%-9.74%-5.86%-28.99%-18.89%
FCF Yield
2.29%1.93%-3.37%-1.96%-25.74%-16.98%
Buyback Yield / Dilution
-30.39%-30.39%-143.61%-96.40%-57.90%-27.39%
Total Shareholder Return
-30.39%-30.39%-143.61%-96.40%-57.90%-27.39%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q